Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients
Связь полиморфизмов провоспалительных и противовоспалительных цитокинов с тяжестью COVID-19 у невакцинированных пациентов
2025-08-13
SCID: 54.1/vpxkmrqq
Discuss with AI
CCL5 rs2107538IL-10 rs1800871IL-10 rs1800872TNFα rs1800629cytokine storm
Figures from the paper
Abstract (AI)
Background Cytokines and chemokines are essential for establishing an appropriate immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Variations in the genes encoding cytokines and chemokines strongly influence the immune response to pathogenic challenges and disease outcomes. This study was conducted to investigate the associations between polymorphisms in the TNF-α, IL-6, IL-8, IL-10, and CCL5 genes and COVID-19 severity. Methodology We performed a cross-sectional study with a total of 627 unvaccinated COVID-19 patients were classified according to WHO disease severity. We evaluated the levels of IFN-α, IFN-γ, TNF-α, IL-1Ra, IL-2, IL-6, IL-7, IL-10, CCL2, CCL3, CXCL8, CXCL10 and GCSF in the serum and compared them among COVID-19 severity groups by Kruskal-Wallis test and stratified by polymorphism alleles. A logistic regression was performed to determine the association of the polymorphism and COVID-19 severity. Results This study revealed a significant increase in IL-2, IL-6 and CCL-2 levels in the deceased group. However, the IL-10 levels were higher in the moderate group than in the mild group. Logistic regression analysis revealed that five polymorphisms were associated with a higher risk of severe COVID-19: the TNF-α (rs1800610) A allele (OR=1.50; 95% CI: 1.01–2.24); the IL-6 (rs1800796) C allele (OR=1.64; 95% CI: 1.05–2.57); the IL-10 (rs1800871) T allele (OR=1.94; 95% CI: 1.24–3.04) and (rs1800872) A allele (OR=1.87; 95% CI: 1.21–2.89); and the CCL5 (rs3817656) G allele (OR= 1.64; 95% CI: 1.02–2.65). Conclusion Patients infected with SARS-CoV-2 who have the TNFα gene variant (rs1800629) are protected from developing COVID-19 moderate and severe outcomes, as well as from presenting low concentrations of some pro-inflammatory cytokines and chemokines. However, carriers of the IL-10 (rs1800872, rs1800871) and CCL-5 (rs2107538) gene variants were associated with patients who died from COVID-19. Of these, only the minor allele of CCL-5 was primarily associated with increased chemokines levels, as well as with some cytokines considered hallmarks of the cytokine storm.
Key Findings
1
Carriers of IL-10 gene variants rs1800872 and rs1800871 are associated with COVID-19 mortality.
2
Carriers of the CCL-5 gene variant rs2107538 are associated with COVID-19 mortality.
3
Carriers of the TNFα gene variant rs1800629 are protected from developing moderate and severe COVID-19 outcomes in unvaccinated patients.
4
TNFα rs1800629 carriers show protection from presenting low concentrations of some pro-inflammatory cytokines and chemokines.
5
The minor allele of CCL-5 rs2107538 is primarily associated with increased chemokine levels and elevated cytokines characteristic of the cytokine storm.
Research Object
Unvaccinated patients infected with SARS-CoV-2 (COVID-19 patients)
Research Subject
Association between pro- and anti-inflammatory cytokine and chemokine gene polymorphisms (TNFα rs1800629, IL-10 rs1800872/rs1800871, CCL5 rs2107538) and COVID-19 severity, mortality, and circulating cytokine/chemokine levels
Publication Details
Publication Date
2025-08-13
Journal
Publisher
ISSN
Cited by
4
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants2023
Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population2023